Bayer AG paid over $2 billion to settle Yaz lawsuits, making it one of the largest pharmaceutical settlements in American legal history. If you used Yaz birth control and suffered a serious health injury, you may still have legal options in 2026.
The Yaz lawsuit story spans more than a decade. Tens of thousands of women filed claims after suffering blood clots, strokes, pulmonary embolisms, and gallbladder disease they linked to the drug.
This article covers everything you need to know right now. You’ll learn who still qualifies, what the payouts looked like, how compensation was structured, and what steps to take if you believe you have a claim.
One number that surprises most people: individual settlement amounts reached as high as $750,000 for the most severe cases.
Yaz Lawsuit 2026: What Is Happening Right Now
The Yaz lawsuit is not a single active class action in 2026. The main wave of settlements was resolved between 2012 and 2015, but individual lawsuits and related claims continued well past that point.
In 2026, the legal situation is more specific. Women who discovered their injuries recently, or who were minors when they used the drug, may still fall within their state’s statute of limitations.
The discovery rule is important here. If you only recently connected your injury to Yaz use, your clock may not have started running yet.
| Litigation Phase | Time Period |
|---|---|
| FDA black box warning added | 2012 |
| MDL-2100 established | 2009 |
| Major Bayer settlements | 2012 to 2015 |
| Remaining individual claims | 2015 to present |
| Potential new claims (discovery rule) | 2024 to 2026 |
Attorneys who handle mass tort cases are still evaluating Yaz claims in 2026. The window is narrow, but it has not completely closed for everyone.
Yaz Lawsuit Settlements: The Full History
Yaz lawsuit settlements totaled more than $2 billion across multiple settlement agreements between Bayer and individual claimants.
The first major settlement round came in 2012, when Bayer agreed to pay approximately $402 million to resolve around 6,760 claims involving blood clot injuries. That was only the beginning.
A second round in 2013 addressed gallbladder injury claims. Bayer set aside roughly $24 million for those cases. Then a third round covering deep vein thrombosis and pulmonary embolism claims added hundreds of millions more.
| Settlement Round | Year | Injury Type | Approximate Amount |
|---|---|---|---|
| Round 1 | 2012 | Blood clots (general) | $402 million |
| Round 2 | 2013 | Gallbladder disease | $24 million |
| Round 3 | 2014 | DVT and pulmonary embolism | $1.1 billion+ |
| Round 4 | 2014-2015 | Stroke and cardiac injury | Hundreds of millions |
These settlements were structured as individual agreements, not one class-wide payout. Each claimant received a separate evaluation based on their injury severity, medical records, and personal circumstances.
Yaz Lawsuit Compensation Amounts: What Bayer Has Paid
Yaz lawsuit compensation amounts varied widely based on the type and severity of the injury. There was no flat payout number that applied to every claimant.
Bayer and plaintiffs’ attorneys used a point-based evaluation system to determine individual awards. Factors like hospitalization length, permanent disability, age at injury, and loss of income all played a role.
Think of it like an insurance adjuster scoring a car accident claim, except the injuries here were far more serious and the stakes were much higher.
Key compensation factors included:
- Type of injury (blood clot vs. stroke vs. gallbladder)
- Severity and duration of the medical episode
- Age of the claimant at the time of injury
- Whether the injury caused permanent disability
- Lost wages and future earning capacity
- Documented medical expenses
Women who suffered fatal pulmonary embolism or stroke had their estates compensated at the highest tiers. Women with resolved gallbladder issues received significantly less.
Key Takeaway: Yaz settlements were not one-size-fits-all. Compensation was tied directly to injury type, severity, and documented losses, which is why individual payouts ranged from a few thousand dollars to hundreds of thousands.
Yaz Lawsuit Payout Per Person: Tier-by-Tier Breakdown
Individual Yaz lawsuit payouts per person ranged from approximately $2,000 to $750,000, depending on the injury category and specific case details.
While Bayer kept the exact settlement matrix confidential, public records and attorney disclosures have given a reasonably clear picture of how much claimants received by injury type.
| Injury Category | Estimated Payout Range |
|---|---|
| Gallbladder disease (resolved) | $2,000 to $15,000 |
| Deep vein thrombosis (DVT) | $15,000 to $75,000 |
| Pulmonary embolism (non-fatal) | $75,000 to $200,000 |
| Stroke (partial recovery) | $100,000 to $400,000 |
| Fatal pulmonary embolism or stroke | $300,000 to $750,000+ |
These figures come from court records and attorney accounts from the MDL proceedings. Individual results varied based on state law, specific medical documentation, and negotiation outcomes.
Attorney fees typically ranged from 33% to 40% of the settlement amount. That means a $100,000 settlement would net approximately $60,000 to $67,000 for the claimant after fees.
Yaz Lawsuit Eligibility: Do You Qualify?
You may be eligible for a Yaz lawsuit if you used Yaz, Yasmin, Beyaz, or a generic equivalent and suffered a serious health complication linked to drospirenone.
Eligibility is not purely about whether you used the drug. You also need a documented injury that occurred during or shortly after your use of the medication.
The basic eligibility checklist looks like this:
- You used Yaz, Yasmin, Beyaz, Ocella, or Safyral
- You suffered one of the recognized injury types (blood clot, stroke, gallbladder disease, cardiac event)
- You have medical records documenting the injury
- Your claim falls within your state’s statute of limitations
- You were not previously compensated through another settlement
Important note on timing: Most states allow 2 to 4 years from the date of injury discovery to file. If you recently connected your health problem to Yaz use, your eligibility window may still be open.
Who Qualifies for a Yaz Lawsuit in 2026?
Women who qualify for a Yaz lawsuit in 2026 are primarily those who either did not participate in earlier settlements, recently discovered their injuries, or were minors at the time of use.
The original MDL settlement rounds closed thousands of cases. But they did not end the legal story for everyone.
Three groups of people may still have standing in 2026:
Group 1: Late injury discoverers. If your doctor only recently linked your health condition to drospirenone use, the statute of limitations may have started running from that recent diagnosis date, not from years ago.
Group 2: Former minors. If you were under 18 when you used Yaz and suffered an injury, many states toll the statute of limitations until you reach adulthood. This could mean your window is still open.
Group 3: Non-settling claimants. Some women filed in the MDL but did not accept settlement offers. A small number of those cases may still be active or eligible for re-evaluation.
| Qualifying Group | Why They May Still Have a Claim |
|---|---|
| Late injury discoverers | Discovery rule resets the clock |
| Former minors | Statute of limitations tolled during minority |
| Non-settling MDL claimants | Some cases remain unresolved |
| New injury connections | Recent medical findings linking old Yaz use |
Key Takeaway: The original Yaz settlement rounds are closed, but specific circumstances like recent injury discovery or minor status at the time of use may keep your 2026 claim legally viable.
Yaz Blood Clot Lawsuit: The Most Common Injury Claim
Blood clot injuries formed the backbone of the Yaz lawsuit, representing the largest share of claims filed against Bayer.
Drospirenone, the synthetic progestin in Yaz, was found in multiple studies to carry a higher risk of venous thromboembolism compared to older-generation birth control pills. That risk is what drove the lawsuits.
A blood clot in the leg (deep vein thrombosis) can break loose and travel to the lungs (pulmonary embolism). That’s life-threatening. Many women had no warning before their clot caused a medical emergency.
Types of blood clot injuries seen in Yaz cases:
- Deep vein thrombosis (DVT) in the leg or pelvis
- Pulmonary embolism (clot in the lung)
- Portal vein thrombosis (clot in liver blood vessel)
- Mesenteric vein thrombosis (clot in intestinal blood vessels)
The FDA issued a safety communication in 2011 warning that drospirenone-containing pills might increase the risk of blood clots by as much as 1.5 to 3 times compared to older pills.
That FDA communication was a turning point. It gave thousands of women the evidence they needed to connect their injuries to Yaz.
Yaz Stroke Lawsuit: When Yaz Led to Neurological Harm
Yaz stroke lawsuits involved women who suffered ischemic strokes they attributed to blood clot formation caused by drospirenone.
Stroke claims generally resulted in higher settlement values than blood clot cases alone, reflecting the severity of permanent neurological damage.
Some women experienced partial or full paralysis. Others lost speech function. A significant number could no longer work after their strokes.
Factors that affected stroke claim values:
- Whether the stroke caused permanent disability
- Age of the claimant at the time of the stroke
- Documented neurological deficits
- Impact on employment and daily living
- Length of hospitalization and rehabilitation
Bayer did not publicly admit that Yaz caused strokes. The company settled these cases without formal admissions of liability, which is standard in mass tort litigation.
For women or their families pursuing stroke-related claims in 2026, the evidentiary bar is high. Medical records showing the stroke, combined with documented Yaz use during the relevant period, are the starting point.
Yaz Gallbladder Lawsuit: A Separate Wave of Claims
Gallbladder injury claims formed a distinct and separate wave of Yaz lawsuits, addressed in their own settlement round beginning in 2013.
Research suggested that hormonal contraceptives containing drospirenone accelerated the formation of gallstones in some women, leading to gallbladder disease and surgical removal.
These claims settled for lower amounts than blood clot and stroke cases, reflecting the difference in injury severity.
| Gallbladder Claim Type | Typical Settlement Range |
|---|---|
| Gallstones with medication treatment | $2,000 to $5,000 |
| Gallstones requiring surgery | $5,000 to $15,000 |
| Complications from surgery | $10,000 to $25,000+ |
Gallbladder cases required proof of Yaz use during the period the condition developed, plus medical documentation of diagnosis and treatment.
Key Takeaway: Gallbladder claims were real and compensable, but they settled at significantly lower values than blood clot or stroke claims. The severity gap between injury types directly shaped how much each claimant received.
Yaz Side Effects Lawsuit: What Injuries Are Covered
Yaz side effects lawsuits covered a specific set of serious injuries, not every side effect listed on the label.
Not every woman who experienced headaches, nausea, or mood changes from Yaz has a viable lawsuit. The claims that led to settlements involved life-altering or life-threatening medical events.
Injuries covered in Yaz litigation:
- Deep vein thrombosis
- Pulmonary embolism
- Ischemic stroke
- Cardiac events linked to clotting
- Gallbladder disease requiring surgery
- Portal vein thrombosis
- Fatal outcomes from any of the above
Injuries not typically covered in the Yaz lawsuits included common hormonal side effects like weight gain, acne, or mood changes. Those were listed as known risks and were not the basis for product liability claims.
If you experienced one of the covered injuries and used Yaz or a drospirenone-based generic, that combination forms the foundation of a potential claim.
Bayer Yaz Lawsuit: The Company’s Legal History
Bayer AG, the German pharmaceutical giant, developed and marketed Yaz through its U.S. subsidiary Bayer HealthCare Pharmaceuticals.
Yaz launched in 2006 and quickly became one of the best-selling birth control pills in the United States. At its peak, it was generating over $1 billion annually in U.S. sales.
The aggressive marketing is part of what made the lawsuits so significant. Bayer ran direct-to-consumer advertising campaigns that regulators later criticized for overstating benefits and understating risks.
Timeline of Bayer’s Yaz legal history:
| Year | Event |
|---|---|
| 2006 | Yaz approved by FDA and launched |
| 2008 | FDA issues warning letter about misleading Yaz ads |
| 2009 | MDL-2100 formed in Southern District of Illinois |
| 2011 | FDA updates drospirenone safety labeling |
| 2012 | First major Bayer settlement round ($402M) |
| 2013 | Gallbladder claim settlements begin |
| 2014-2015 | Largest settlement rounds concluded |
| 2020s | Continued individual litigation |
Bayer never admitted that Yaz caused the injuries at the center of the lawsuits. The company maintained that the drug was safe when used as directed. Settlements were described by Bayer as a business decision to avoid prolonged litigation costs.
Yaz MDL Settlement: How the Multidistrict Litigation Worked
The Yaz MDL (Multidistrict Litigation) was formally designated as MDL-2100 and assigned to the Southern District of Illinois under Judge David Herndon.
MDL is not the same as a class action. In a class action, one verdict applies to everyone. In an MDL, cases are grouped together for pretrial efficiency, but each plaintiff’s case remains individual.
Think of an MDL like an assembly line. Thousands of similar cases get organized, evidence is shared, and bellwether trials test legal theories, but each claimant ultimately gets their own assessment.
How MDL-2100 worked:
- Over 10,000 cases were consolidated in MDL-2100
- Bellwether trials helped establish settlement values
- Bayer negotiated global settlements with plaintiffs’ steering committees
- Individual claimants had to opt into settlement agreements
- Cases that rejected settlement offers could still proceed to trial
The MDL structure allowed plaintiffs’ attorneys to pool resources and share discovery costs. That made it possible for individual claimants with limited means to take on a billion-dollar pharmaceutical company.
Key Takeaway: The Yaz MDL gave tens of thousands of women access to justice they could not have afforded individually. The collective litigation structure was central to extracting the $2 billion-plus in settlements from Bayer.
Yaz Drospirenone Lawsuit: The Science Behind the Claims
Drospirenone is the synthetic progestin that separates Yaz from older-generation birth control pills, and it is the ingredient at the heart of every Yaz lawsuit.
Older pills used progestins like levonorgestrel and norgestimate. Drospirenone was newer and marketed as offering skin-clearing and anti-bloating benefits. That marketing attracted millions of users.
The problem was that drospirenone appeared to have a higher thrombogenic (clot-causing) profile than older progestins.
Key studies that shaped the litigation:
| Study | Finding |
|---|---|
| 2011 British Medical Journal (BMJ) study | Drospirenone pills associated with 6x higher clot risk vs. non-use |
| 2012 BMJ study | Drospirenone carried 1.5 to 3x higher clot risk vs. levonorgestrel pills |
| FDA 2011 Safety Communication | Confirmed increased VTE risk with drospirenone |
| 2013 FDA label update | Required stronger clot risk warning language |
These studies gave plaintiffs the scientific foundation they needed. They showed that drospirenone was not just a hormonal contraceptive risk in general. It carried an elevated risk compared to the alternatives Bayer chose not to mention in its ads.
Bayer disputed the science throughout the litigation. But the FDA’s own safety communications sided with the concerns, which significantly strengthened plaintiffs’ cases.
Yaz Class Action Lawsuit vs. Mass Tort: What’s the Difference
The Yaz lawsuit was a mass tort, not a traditional class action. Understanding the difference matters because it affects how compensation works.
In a class action, all plaintiffs share one settlement equally. In a mass tort, each person’s case is evaluated individually based on their specific injuries and losses.
Class Action vs. Mass Tort comparison:
| Feature | Class Action | Mass Tort (Yaz MDL) |
|---|---|---|
| Cases combined? | Yes | Yes, for pretrial purposes |
| Same verdict for all? | Yes | No, individual assessments |
| Compensation equal? | Yes | No, based on injury severity |
| Individual lawyer needed? | Not always | Yes, strongly advisable |
| Typical for drug injuries? | Rarely | Yes, standard approach |
The mass tort structure was better for Yaz claimants. A woman who suffered a fatal pulmonary embolism deserved far more compensation than someone who had a resolved blood clot. Equal payouts would have been unjust in both directions.
This distinction also means that in 2026, if you have a late-filed individual claim, it is evaluated on its own merits. You are not competing for a share of a fixed pool.
Yaz Lawsuit Lawyer: How to Choose the Right Attorney
A Yaz lawsuit lawyer is a personal injury or mass tort attorney who specializes in pharmaceutical litigation against Bayer.
Choosing the right lawyer in 2026 matters more than it did in 2012. The major settlement rounds are closed. Any claim filed now requires an attorney who knows the current legal terrain, not one recycling ten-year-old strategies.
What to look for in a Yaz lawsuit lawyer:
- Specific experience with pharmaceutical mass tort cases
- Track record of Yaz, Yasmin, or similar drug litigation
- Willingness to take the case on contingency (no upfront fees)
- Clear communication about the strength and limitations of your claim
- Access to medical experts who can support your case
Red flags to avoid:
- Lawyers who guarantee specific payout amounts before reviewing your case
- Firms that cannot name specific Yaz or pharmaceutical cases they’ve handled
- Anyone asking for upfront money before filing
- Attorneys who cannot explain the current statute of limitations for your state
Key Takeaway: Your choice of attorney in 2026 is critical. Late-filed Yaz claims require lawyers with specific mass tort experience and current knowledge of drospirenone litigation, not just general personal injury practitioners.
How to File a Yaz Lawsuit in 2026
Filing a Yaz lawsuit in 2026 starts with confirming that your claim is still within the statute of limitations for your state.
The filing process has several stages, and it begins long before any paperwork reaches a courthouse.
Step-by-step filing process:
- Gather your medical records. You need documentation of your Yaz prescription, your injury diagnosis, and all related treatment.
- Confirm your Yaz use dates. Pharmacy records, insurance claims, or prescription bottles showing your use period are critical.
- Consult a mass tort attorney. Most offer free case evaluations. They will assess whether your claim has legal merit and whether it falls within the filing window.
- Undergo case evaluation. Your attorney will review your records, consult with medical experts, and determine the likely value of your claim.
- File your complaint. Your attorney files the legal complaint, either in federal court or as part of any remaining MDL proceedings.
- Discovery and negotiation. Evidence is exchanged, and settlement negotiations begin. Most mass tort cases settle before trial.
| Stage | What Happens |
|---|---|
| Case evaluation | Attorney reviews your records and injury history |
| Complaint filing | Legal action formally begins |
| Discovery | Both sides exchange evidence |
| Settlement negotiation | Bayer and plaintiffs negotiate compensation |
| Resolution | Claim settles or proceeds to trial |
Most attorneys handle Yaz cases on contingency. You pay nothing unless you win. That removes the financial barrier for most claimants.
Yaz Lawsuit Status 2026: Where Things Stand Today
The Yaz lawsuit status in 2026 reflects a litigation cycle that has largely wound down for mass settlements but remains open for specific individual circumstances.
The MDL-2100 docket has been dramatically reduced from its peak of over 10,000 cases. Most claims resolved through Bayer’s settlement rounds between 2012 and 2015. A smaller number of holdout cases continued through the late 2010s and into the 2020s.
What remains active in 2026 falls into two categories.
Category 1: Individual late-filed claims. These are cases where claimants either recently discovered the connection between their injury and Yaz use, or where the statute of limitations was tolled for another reason like minor status or fraudulent concealment.
Category 2: Appeals and unresolved MDL cases. A small number of cases from the original MDL that were not settled and proceeded to trial are still in various stages of appeal or resolution.
| 2026 Yaz Lawsuit Status | Description |
|---|---|
| Mass settlement rounds | Closed (2012 to 2015) |
| MDL-2100 active docket | Significantly reduced |
| New individual claims | Possible under discovery rule |
| Appeals from trial verdicts | Some may still be active |
| Statute of limitations | Varies by state (2 to 4 years from discovery) |
If you have not yet explored whether you have a viable claim, 2026 may be one of the last realistic windows. Waiting longer only narrows your options further.
The Yaz lawsuit story is not entirely over. But for most people, the time to act is right now, not later.
Frequently Asked Questions
Can I still file a Yaz lawsuit in 2026?
Some people may still be able to file a Yaz lawsuit in 2026.
If you recently connected your health condition to Yaz use, the discovery rule in many states starts the statute of limitations from that date, not from when you took the pill.
Consulting a mass tort attorney is the fastest way to know whether your specific circumstances keep your claim alive.
How much money can I get from a Yaz lawsuit settlement?
Individual Yaz lawsuit settlements ranged from roughly $2,000 for minor gallbladder cases to over $750,000 for fatal or severely disabling injuries.
The exact amount depends on your injury type, medical documentation, and the severity of your condition.
Attorney fees of 33% to 40% are typically deducted from the gross settlement amount before you receive payment.
What injuries qualify for a Yaz lawsuit?
The injuries that qualify for a Yaz lawsuit include deep vein thrombosis, pulmonary embolism, ischemic stroke, cardiac events linked to blood clots, gallbladder disease requiring surgery, and fatal outcomes from those conditions.
Common side effects like mood changes, nausea, or headaches did not form the basis for successful Yaz claims.
You need documented medical records connecting your serious injury to your period of Yaz use.
How long does a Yaz lawsuit take to settle?
Yaz lawsuits within the original MDL took between 1 and 4 years to resolve from the time of filing.
Individual claims filed in 2026 could take a similar timeframe depending on negotiation complexity and whether your case requires a trial.
Cases with strong medical documentation and clear injury timelines tend to resolve faster.
What does a Yaz lawsuit lawyer charge?
Most Yaz lawsuit lawyers work on a contingency fee basis, meaning they charge no upfront costs.
If your case settles or wins at trial, your attorney typically takes 33% to 40% of the total recovery.
If your case does not result in any compensation, you owe nothing in legal fees.
Your Next Step
The Yaz lawsuit resulted in more than $2 billion in settlements because Bayer marketed a drug with a higher clotting risk than older alternatives, and thousands of women paid the price.
If you used Yaz and suffered a blood clot, stroke, or gallbladder injury, the question in 2026 is simple: does your case still fall within the legal window? An attorney who handles pharmaceutical mass torts can answer that in a free consultation.
Don’t let more time pass without getting a clear answer. The statute of limitations is the one deadline that can eliminate your legal options permanently.
